Spots Global Cancer Trial Database for Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
Official Title: Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)
Study ID: NCT01496573
Interventions
Study Description
Brief Summary: This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Detailed Description: PRIMARY OBJECTIVES: I. To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by tissue microarray (TMA). OUTLINE: Archived tumor tissue samples are analyzed for CRKL expression.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Children's Oncology Group, Monrovia, California, United States
Contact Details
Name: Lee Helman, MD
Affiliation: Children's Oncology Group
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
